TLR9 and systemic lupus erythematosus: Activation by LPS and TLR9 agonist triggered significant changes in lectin binding of both HC and SLE monocyte subsets, and there was no significant difference between HC and SLE in the lectin binding ratio between the activated and resting state (Figure 8C).